CHRS
Coherus BioSciences Inc
Price:  
1.67 
USD
Volume:  
1,301,309.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS Stock Forecast & Price Target

CHRS Stock Price Forecast

The average stock forecast for Coherus BioSciences Inc (CHRS) in the next 12 months is 10.64 USD. This price target corresponds to an upside of 536.96%. The range of stock forecasts for CHRS is 4.04 - 24.15 USD. Based on the ratings of 16 analysts, the consensus recommendation for CHRS is BUY.
Target Low Average Median High
Price (USD) 4.04 10.64 9.18 24.15
Upside 141.92% 536.96% 449.70% 1,346.11%

Recommendation Trends

The latest consensus rating for CHRS is "BUY". This is the average recommendation of 16 analysts: 0 strong sell, 0 sell, 3 hold, 9 buy, 4 strong buy. In the previous period, 16 analysts also majorly recommmended "BUY" for CHRS.

CHRS Financial Stock Forecast

Revenue This Year
261.58M
1.69%
from 257.24M
Revenue Next Year
335.52M
28.26%
from 261.58M
EPS This Year
-1.38
-33.22%
from -2.07
EPS Next Year
-0.19
-86.57%
from -1.38